# Effect of ARNI in Patients With Persistent AF and Enlarged Left Atrium After Catheter Ablation

> **NCT03791723** · NA · UNKNOWN · sponsor: **The Second Affiliated Hospital of Chongqing Medical University** · enrollment: 90 (estimated)

## Conditions studied

- Atrial Fibrillation
- Cardiac Remodeling, Atrial
- Sacubitril/Valsartan

## Interventions

- **DRUG:** Sacubitril-Valsartan
- **DRUG:** Valsartan

## Key facts

- **NCT ID:** NCT03791723
- **Lead sponsor:** The Second Affiliated Hospital of Chongqing Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-06-01
- **Primary completion:** 2021-01-01
- **Final completion:** 2021-12-30
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2019-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03791723

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03791723, "Effect of ARNI in Patients With Persistent AF and Enlarged Left Atrium After Catheter Ablation". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT03791723. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*